Literature DB >> 19906238

Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders.

George P Chrousos1, Tomoshige Kino.   

Abstract

Glucocorticoids contribute to the maintenance of basal and stress-related homeostasis in all higher organisms, and influence a large proportion of the expressed human genome, and their effects spare almost no organs or tissues. Glucocorticoids regulate many functions of the central nervous system, such as arousal, cognition, mood, sleep, the activity and direction of intermediary metabolism, the maintenance of a proper cardiovascular tone, the activity and quality of the immune and inflammatory reaction, including the manifestations of the sickness syndrome, and growth and reproduction. The numerous actions of glucocorticoids are mediated by a set of at least 16 glucocorticoid receptor (GR) isoforms forming homo- or hetero-dimers. The GRs consist of multifunctional domain proteins operating as ligand-dependent transcription factors that interact with many other cell signaling systems, including large and small G proteins. The presence of multiple GR monomers and homo- or hetero-dimers expressed in a cell-specific fashion at different quantities with quantitatively and qualitatively different transcriptional activities suggest that the glucocorticoid signaling system is highly stochastic. Glucocorticoids are heavily involved in human pathophysiology and influence life expectancy. Common behavioral and/or somatic complex disorders, such as anxiety, depression, insomnia, chronic pain and fatigue syndromes, obesity, the metabolic syndrome, essential hypertension, diabetes type 2, atherosclerosis with its cardiovascular sequelae, and osteoporosis, as well as autoimmune inflammatory and allergic disorders, all appear to have a glucocorticoid-regulated component.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906238      PMCID: PMC2791367          DOI: 10.1111/j.1749-6632.2009.04988.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  70 in total

1.  The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture.

Authors:  G P Chrousos
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 2.  Intracellular glucocorticoid signaling: a formerly simple system turns stochastic.

Authors:  George P Chrousos; Tomoshige Kino
Journal:  Sci STKE       Date:  2005-10-04

Review 3.  Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.

Authors:  Evangelia Charmandari; Tomoshige Kino; Takamasa Ichijo; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

4.  The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications.

Authors:  Takamasa Ichijo; Antonis Voutetakis; Ana P Cotrim; Nisan Bhattachryya; Makiko Fujii; George P Chrousos; Tomoshige Kino
Journal:  J Biol Chem       Date:  2005-10-25       Impact factor: 5.157

5.  The N363S polymorphism of the glucocorticoid receptor and metabolic syndrome factors in men.

Authors:  Benjamin Buemann; Eva Black; Claus Holst; Søren Toubro; Søren Echwald; Oluf Pedersen; Arne Astrup; Thorkild Sørensen
Journal:  Obes Res       Date:  2005-05

Review 6.  Tissue glucocorticoid sensitivity: beyond stochastic regulation on the diverse actions of glucocorticoids.

Authors:  T Kino
Journal:  Horm Metab Res       Date:  2007-06       Impact factor: 2.936

Review 7.  Glucocorticoid action networks and complex psychiatric and/or somatic disorders.

Authors:  George P Chrousos; Tomoshige Kino
Journal:  Stress       Date:  2007-06       Impact factor: 3.493

8.  Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress.

Authors:  Tomoshige Kino; Takamasa Ichijo; Niranjana D Amin; Sashi Kesavapany; Yonghong Wang; Nancy Kim; Sandesh Rao; Audrey Player; Ya-Li Zheng; Michael J Garabedian; Ernest Kawasaki; Harish C Pant; George P Chrousos
Journal:  Mol Endocrinol       Date:  2007-04-17

9.  A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance.

Authors:  Evangelia Charmandari; Tomoshige Kino; Takamasa Ichijo; William Jubiz; Liliana Mejia; Keith Zachman; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2007-07-17       Impact factor: 5.958

10.  G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus.

Authors:  Tomoshige Kino; Anatoly Tiulpakov; Takamasa Ichijo; Ly Chheng; Tohru Kozasa; George P Chrousos
Journal:  J Cell Biol       Date:  2005-06-13       Impact factor: 10.539

View more
  63 in total

1.  Chronic, noninvasive glucocorticoid administration suppresses limbic endocannabinoid signaling in mice.

Authors:  N P Bowles; M N Hill; S M Bhagat; I N Karatsoreos; C J Hillard; B S McEwen
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

2.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

Authors:  Amal Melhem-Bertrandt; Mariana Chavez-Macgregor; Xiudong Lei; Erika N Brown; Richard T Lee; Funda Meric-Bernstam; Anil K Sood; Suzanne D Conzen; Gabriel N Hortobagyi; Ana-Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

Review 3.  Cortisol and finfish welfare.

Authors:  Tim Ellis; Hijran Yavuzcan Yildiz; Jose López-Olmeda; Maria Teresa Spedicato; Lluis Tort; Øyvind Øverli; Catarina I M Martins
Journal:  Fish Physiol Biochem       Date:  2011-11-24       Impact factor: 2.794

Review 4.  Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Endocr Dev       Date:  2010-12-16

Review 5.  Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.

Authors:  Evangelia Charmandari; Tomoshige Kino
Journal:  Eur J Clin Invest       Date:  2010-08-19       Impact factor: 4.686

6.  Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children.

Authors:  M N Edelmann; C A Sandman; L M Glynn; D A Wing; E P Davis
Journal:  Psychoneuroendocrinology       Date:  2016-06-23       Impact factor: 4.905

7.  Role of BCL2-associated athanogene 1 in differential sensitivity of human endothelial cells to glucocorticoids.

Authors:  Eugenia Mata-Greenwood; John M Stewart; Robin H Steinhorn; William J Pearce
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-14       Impact factor: 8.311

Review 8.  Conference summary and conclusions. A comprehensive approach to predicting and managing mood effects of glucocorticoids.

Authors:  Esther M Sternberg; Lewis L Judd
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 9.  Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics.

Authors:  Andrea H Marques; Marni N Silverman; Esther M Sternberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 10.  Complex genomic interactions in the dynamic regulation of transcription by the glucocorticoid receptor.

Authors:  Tina B Miranda; Stephanie A Morris; Gordon L Hager
Journal:  Mol Cell Endocrinol       Date:  2013-03-14       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.